ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 107

$498K Total Retail Price of All Prescriptions

Rank: 31 out of 107

352 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

7% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,067 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 547 546 1 5
LISINOPRIL 468 447 2 4
DONEPEZIL HCL 432 432 3 10
METOPROLOL TARTRATE 419 397 4 7
SIMVASTATIN 413 410 5 2
WARFARIN SODIUM 400 400 6 8
HYDROCHLOROTHIAZIDE 302 302 7 14
FUROSEMIDE 264 250 8 3
LEVOTHYROXINE SODIUM 264 260 8 1
OMEPRAZOLE 258 248 10 6
NAMENDA 238 238 11 19
GABAPENTIN 213 181 12 11
SERTRALINE HCL 207 195 13 12
MIRTAZAPINE 194 187 14 16
ALENDRONATE SODIUM 145 131 15 35
CLOPIDOGREL 140 127 16 29
METFORMIN HCL 131 129 17 13
TRAZODONE HCL 131 116 17 22
LOVASTATIN 122 122 19 51
ESCITALOPRAM OXALATE 118 110 20 40
FENTANYL 117 117 S2 21 50
METOPROLOL SUCCINATE 116 113 22 15
PANTOPRAZOLE SODIUM 113 111 23 28
ATORVASTATIN CALCIUM 112 112 24 17
CARVEDILOL 112 92 24 25
TAMSULOSIN HCL 109 80 26 27
RISPERIDONE 104 104 27 26
GLIPIZIDE 104 104 27 46
DIOVAN 94 94 29 33
CITALOPRAM HBR 94 91 29 9
LATANOPROST 90 90 31 94
ATENOLOL 87 67 32 21
PLAVIX 81 76 33 43
DIGOXIN 80 80 34 37
TRAMADOL HCL 75 74 35 23
IPRATROPIUM-ALBUTEROL 73 72 36 49
POTASSIUM CHLORIDE 71 70 37 18
RANITIDINE HCL 71 59 37 41
SANTYL 69 67 39 113
ADVAIR DISKUS 68 65 40 47
LEVETIRACETAM 67 41 41 44
OXYCODONE-ACETAMINOPHEN 66 64 S2 42 53
LANTUS 65 63 43 34
QUETIAPINE FUMARATE 64 59 44 31
ENALAPRIL MALEATE 64 62 44 70
POLYETHYLENE GLYCOL 3350 60 58 46 24
ISOSORBIDE MONONITRATE ER 59 59 47 30
CRESTOR 53 43 48 63
LOSARTAN POTASSIUM 52 52 49 36
VERAPAMIL ER 51 51 50 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.